This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Ablexis/AlivaMab Discovery Services


Ablexis, LLC created and commercializes the AlivaMab Mouse technology, a unique, patented next generation transgenic mouse platform for human therapeutic antibody discovery. Ablexis has non-exclusively licensed the AlivaMab Mouse technology to multiple companies, including global

pharmaceutical companies, public and private biotechnology companies and other entities. Ablexis

continues making the AlivaMab Mouse available via non-exclusive licenses. For more information, visit For inquiries about licensing AlivaMab Mouse, contact us at


We're bringing you

  • Quality. Speed. Value. Therapeutic Antibody Discovery in Challenging Projects Using AlivaMab® Mouse and AlivaMab Discovery Services

  • AlivaMab® Discovery Services: Successful Antibody Drug Discovery Campaigns Against Difficult Targets